Multiple dose study for MR product in EU [Regulatives / Guidelines]
❝ "A multiple dose study is needed unless a single dose study has been performed with the highest strength which has demonstrated that the mean AUC(0-τ) after the first dose covers more than 90% of mean AUC(0-∞) for both test and reference, and consequently a low extent of accumulation is expected".
❝
❝ Please elaborate or simplify the same for better understanding.
Dear Mahesh,
You can consider "first dose" as a "single dose" study.
For MR products in EMEA, first perform pivotal BE study under fasting state and evalaute the results. If AUC0-t>0.9*AUCinf, you need not to go ahead for steady state BE study. BE under steady state is required when drug accumulates in body. If AUC0-t> 0.9*AUCinf is achieved after signle dose administration, normally, there would not be accumulation.
You can refer following posts as well: #12612, #7062, #8296
Hope this info would be helpful.
Regards,
Samaya.
Edit: Full quote removed. Please delete everything from the text of the original poster which is not necessary in understanding your answer; see also this post! [Helmut]
Complete thread:
- Multiple dose study for MR product in EU Mahesh M 2014-09-26 11:53 [Regulatives / Guidelines]
- Multiple dose study for MR product in EUSamaya B 2014-09-27 11:06
- Multiple dose study for MR product in EU jalgorta 2017-03-14 14:18
- Multiple dose study for MR product in EUSamaya B 2014-09-27 11:06